Once released in extracellular vesicles (EV) from cancer-associated fibroblasts (CAFs) in the extracellular matrix, Annexin A6 activates a β1 integrin-focal adhesion kinase (FAK)-YAP axis. This evidence concerns the gene YAP1 and cancer.